CompoAtlas

PODIEX

Natural health product licensed in Canada

Other names
Podiex Extra
Licence holder
Biosambucus
NPN or DIN-HM
80131459
Status
Active licence
Licence date
27 May 2024
Revision date
Not provided
Form
Huile
Route of administration
Topique
Application type
Générale (non traditionelle)

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Melaleuca alternifolia100 % (v/v)

Non-medicinal ingredients

Not provided.

PopulationAgeQuantity per servingFrequency
Adultesminimum: 18 years1 Portions2 Tous les jours

Uses authorised in Canada

Aide à améliorer les symptômes des infections fongiques du lit des ongles (onychomycose).

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80131459

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line